EyePoint Pharmaceuticals, Inc. (EYPT)
USD 7.3
(2.38%)
USD 7.3
(2.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 46.01 Million | 41.4 Million | 36.93 Million | 34.43 Million | 20.36 Million | 2.96 Million |
| Cost of Revenue | 4.63 Million | 8.32 Million | 8.17 Million | 5.82 Million | 2.68 Million | 18.5 Million |
| Gross Profit | 41.38 Million | 33.07 Million | 28.76 Million | 28.61 Million | 17.67 Million | -15.54 Million |
| Operating Expenses | 116.45 Million | 112.01 Million | 84.03 Million | 65.9 Million | 65.53 Million | 29.23 Million |
| Selling, General and Administrative Expenses | 51.79 Million | 60.32 Million | 53.07 Million | 46.01 Million | 47.71 Million | 13.05 Million |
| Research and Development Expenses | 64.66 Million | 49.64 Million | 28.5 Million | 17.42 Million | 15.36 Million | 16.17 Million |
| Other Expenses | - | 2.05 Million | 2.46 Million | 2.46 Million | 2.46 Million | 14.83 Million |
| Cost and Expenses | 121.08 Million | 120.34 Million | 92.21 Million | 71.72 Million | 68.22 Million | 29.23 Million |
| Operating Income | -73.66 Million | -78.93 Million | -55.27 Million | -37.29 Million | -47.86 Million | -26.27 Million |
| Interest Expense | 1.24 Million | 3.18 Million | 5.49 Million | 7.25 Million | 6.17 Million | 720 Thousand |
| Income Tax Expense | 83 Thousand | 22.25 Million | 5.49 Million | 7.25 Million | 6.17 Million | -25.55 Million |
| Earnings before Tax | -70.71 Million | -102.25 Million | -58.41 Million | -45.39 Million | -56.79 Million | -53.17 Million |
| Net Income | -70.79 Million | -124.51 Million | -63.91 Million | -52.65 Million | -62.96 Million | -53.17 Million |
| Earnings Per Share Basic | -1.82 | -3.34 | -2.22 | -4.10 | -6.04 | -11.50 |
| Earnings Per Share Diluted | -1.82 | -3.34 | -2.22 | -4.10 | -6.04 | -11.50 |
| Weighted Average Shares Outstanding | 38.9 Million | 37.31 Million | 28.75 Million | 12.83 Million | 10.43 Million | 4.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.9 Million | 37.31 Million | 28.75 Million | 12.83 Million | 10.43 Million | 4.62 Million |
| Gross Margin | 0.90 | 0.80 | 0.78 | 0.83 | 0.87 | -5.25 |
| EBIT Margin | -1.50 | -1.81 | -1.42 | -1.01 | -2.18 | -8.84 |
| Profit Margin | -1.54 | -3.01 | -1.73 | -1.53 | -3.09 | -17.96 |
| EBITDA | -69 Million | -96.61 Million | -50.14 Million | -35.48 Million | -48.01 Million | -36.99 Million |
| Earnings Before Tax Margin | -1.60 | -1.91 | -1.50 | -1.08 | -2.35 | -8.87 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.47 Million | 11.68 Million | 14.02 Million | 46.01 Million | 15.2 Million | 9.1 Million |
| Cost of Revenue | 1.4 Million | 759 Thousand | 998 Thousand | 4.63 Million | 1.2 Million | 1.79 Million |
| Gross Profit | 8.07 Million | 10.92 Million | 13.03 Million | 41.38 Million | 14 Million | 7.31 Million |
| Operating Expenses | 42.62 Million | 44.24 Million | 29.38 Million | 115.04 Million | 28.39 Million | 30.07 Million |
| Selling, General and Administrative Expenses | 12.8 Million | 14.1 Million | 11.43 Million | - | 11.03 Million | 14.34 Million |
| Research and Development Expenses | 29.82 Million | 30.13 Million | 17.95 Million | - | 17.36 Million | 15.73 Million |
| Other Expenses | -4.12 Million | - | - | - | - | - |
| Cost and Expenses | 44.02 Million | 45 Million | 30.38 Million | 119.68 Million | 29.6 Million | 31.86 Million |
| Operating Income | -34.54 Million | -33.32 Million | -16.35 Million | -73.66 Million | -14.39 Million | -22.76 Million |
| Interest Expense | - | - | - | 1.24 Million | - | 435 Thousand |
| Income Tax Expense | - | -1.00 | 83 Thousand | 83 Thousand | 1.82 Million | -1.18 Million |
| Earnings before Tax | -30.82 Million | -29.28 Million | -14.01 Million | -70.71 Million | -12.61 Million | -22.92 Million |
| Net Income | -30.82 Million | -29.28 Million | -14.09 Million | -70.79 Million | -12.61 Million | -22.92 Million |
| Earnings Per Share Basic | -0.58 | -0.55 | -0.33 | - | -0.33 | -0.61 |
| Earnings Per Share Diluted | -0.58 | -0.55 | -0.33 | - | -0.33 | -0.61 |
| Weighted Average Shares Outstanding | 53.2 Million | 52.91 Million | 42.16 Million | 38.9 Million | 38.34 Million | 37.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.2 Million | 52.91 Million | 42.16 Million | 38.9 Million | 38.34 Million | 37.57 Million |
| Gross Margin | 0.85 | 0.94 | 0.93 | 0.90 | 0.92 | 0.80 |
| EBIT Margin | -3.61 | -2.83 | -1.16 | - | -0.83 | -2.32 |
| Profit Margin | -3.25 | -2.51 | -1.01 | -1.54 | -0.83 | -2.52 |
| EBITDA | -34.18 Million | -33.01 Million | -16.24 Million | - | -12.61 Million | -21.13 Million |
| Earnings Before Tax Margin | -3.65 | -2.85 | -1.17 | -1.60 | -0.95 | -2.50 |
CITY
ZOMATO
BIRMF
TRGNF
AEWU
CGBS